| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2969974 | The Journal of Heart and Lung Transplantation | 2015 | 10 Pages |
Abstract
Patients with HF and advanced liver dysfunction are high-risk HTx candidates. Liver biopsy in addition to MELD-XI improves risk stratification of patients with advanced HF and suspected irreversible liver dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maryjane MD, MSc, James MD, Matthew BA, Tomoko S. MD, PhD, Zhezhen PhD, Paul MPH, Lorna MD, Ulrich P. MD, Hiroo MD, PhD, Jean MD, Yoshifumi MD, PhD, Donna MD, Jay H. MD, P. MD, PhD,